Genus PLC banner

Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 2 525 GBX 1.41% Market Closed
Market Cap: £1.7B

Profitability Summary

Genus PLC's profitability score is 46/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score
46/100
Profitability
Score

Margins

Earnings Waterfall
Genus PLC

Margins Comparison
Genus PLC Competitors

Country Company Market Cap Operating
Margin
Net
Margin
UK
Genus PLC
LSE:GNS
1.7B GBP
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
373.2B USD
Loading...
Loading...
US
Exact Sciences Corp
NASDAQ:EXAS
356.4B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
190.4B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169.9B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
69.6B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Genus PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Genus PLC
LSE:GNS
1.7B GBP
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
373.2B USD
Loading...
Loading...
Loading...
Loading...
US
Exact Sciences Corp
NASDAQ:EXAS
356.4B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
190.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169.9B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
69.6B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Genus PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett